S505N mutation is likewise found but much less commonly than in hereditary thrombocytosis. Rarer mutations of MPLAutonomous activation in the JAK/STAT pathway is central in numerous pathologies. Genetic alterations focusing on this signaling pathway are connected mainly with hematologic malignancies. Pathological JAK activation also takes place in